Human Gene HTRA2 (ENST00000258080.8_4) from GENCODE V47lift37
  Description: HtrA serine peptidase 2, transcript variant 5 (from RefSeq NR_135769.1)
Gencode Transcript: ENST00000258080.8_4
Gencode Gene: ENSG00000115317.13_8
Transcript (Including UTRs)
   Position: hg19 chr2:74,757,060-74,760,446 Size: 3,387 Total Exon Count: 8 Strand: +
Coding Region
   Position: hg19 chr2:74,757,134-74,760,112 Size: 2,979 Coding Exon Count: 8 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr2:74,757,060-74,760,446)mRNA (may differ from genome)Protein (458 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCHuman Cortex Gene ExpressionMalacardsMGIOMIMPubMed
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: HTRA2_HUMAN
DESCRIPTION: RecName: Full=Serine protease HTRA2, mitochondrial; EC=3.4.21.108; AltName: Full=High temperature requirement protein A2; Short=HtrA2; AltName: Full=Omi stress-regulated endoprotease; AltName: Full=Serine protease 25; AltName: Full=Serine proteinase OMI; Flags: Precursor;
FUNCTION: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive.
CATALYTIC ACTIVITY: Cleavage of non-polar aliphatic amino-acids at the P1 position, with a preference for Val, Ile and Met. At the P2 and P3 positions, Arg is selected most strongly with a secondary preference for other hydrophilic residues.
SUBUNIT: Homotrimer. Interacts with MXI2. Interacts with THAP5 under apoptotic conditions. The mature protein, but not the precursor, binds to BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4. Interacts with BIRC6/bruce.
INTERACTION: Q96CA5:BIRC7; NbExp=2; IntAct=EBI-517086, EBI-517623; P02666:CSN2 (xeno); NbExp=2; IntAct=EBI-517086, EBI-5260183; Q9P0J0:NDUFA13; NbExp=6; IntAct=EBI-517086, EBI-372742; Q60855:Ripk1 (xeno); NbExp=2; IntAct=EBI-517086, EBI-529119; P98170:XIAP; NbExp=10; IntAct=EBI-517086, EBI-517127;
SUBCELLULAR LOCATION: Mitochondrion intermembrane space. Mitochondrion membrane; Single-pass membrane protein (Potential). Note=Predominantly present in the intermembrane space. Released into the cytosol following apoptotic stimuli, such as UV treatment, and stimulation of mitochondria with caspase-8 truncated BID/tBID.
TISSUE SPECIFICITY: Isoform 1 is ubiquitous. Isoform 2 is expressed predominantly in the kidney, colon and thyroid.
DOMAIN: The mature N-terminus is involved in the interaction with XIAP.
DOMAIN: The PDZ domain mediates interaction with MXI2.
PTM: Autoproteolytically activated.
DISEASE: Defects in HTRA2 are the cause of Parkinson disease type 13 (PARK13) [MIM:610297]. A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain.
SIMILARITY: Belongs to the peptidase S1B family.
SIMILARITY: Contains 1 PDZ (DHR) domain.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: HTRA2
Diseases sorted by gene-association score: 3-methylglutaconic aciduria, type viii* (1200), parkinson disease 13* (903), htra2-related parkinson disease* (100), 3-methylglutaconic aciduria (18), ophthalmomyiasis (11), anteroseptal myocardial infarction (9), parkinson disease, juvenile, type 2* (8), tremor (8), lateral myocardial infarction (7), essential tremor (7)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 41.40 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 1034.17 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -38.1074-0.515 Picture PostScript Text
3' UTR -95.50334-0.286 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001478 - PDZ
IPR009003 - Pept_cys/ser_Trypsin-like
IPR001254 - Peptidase_S1_S6
IPR001940 - Peptidase_S1C

Pfam Domains:
PF00089 - Trypsin
PF00595 - PDZ domain
PF13180 - PDZ domain
PF13365 - Trypsin-like peptidase domain
PF17820 - PDZ domain

SCOP Domains:
50156 - PDZ domain-like
50494 - Trypsin-like serine proteases

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1LCY - X-ray MuPIT 2PZD - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on O43464
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details Gene Details  
Gene SorterGene Sorter Gene Sorter  
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004252 serine-type endopeptidase activity
GO:0005515 protein binding
GO:0008233 peptidase activity
GO:0008236 serine-type peptidase activity
GO:0016787 hydrolase activity
GO:0042802 identical protein binding
GO:0051082 unfolded protein binding

Biological Process:
GO:0006508 proteolysis
GO:0006672 ceramide metabolic process
GO:0006915 apoptotic process
GO:0007005 mitochondrion organization
GO:0007568 aging
GO:0007628 adult walking behavior
GO:0008344 adult locomotory behavior
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage
GO:0009635 response to herbicide
GO:0010822 positive regulation of mitochondrion organization
GO:0010942 positive regulation of cell death
GO:0016540 protein autoprocessing
GO:0019742 pentacyclic triterpenoid metabolic process
GO:0030900 forebrain development
GO:0034599 cellular response to oxidative stress
GO:0034605 cellular response to heat
GO:0035458 cellular response to interferon-beta
GO:0040014 regulation of multicellular organism growth
GO:0043065 positive regulation of apoptotic process
GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0044257 cellular protein catabolic process
GO:0045786 negative regulation of cell cycle
GO:0048666 neuron development
GO:0060548 negative regulation of cell death
GO:0070207 protein homotrimerization
GO:0071300 cellular response to retinoic acid
GO:0071363 cellular response to growth factor stimulus
GO:0097193 intrinsic apoptotic signaling pathway
GO:0097194 execution phase of apoptosis
GO:1901215 negative regulation of neuron death
GO:1902176 negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
GO:1903146 regulation of mitophagy
GO:1903955 positive regulation of protein targeting to mitochondrion
GO:1904924 negative regulation of mitophagy in response to mitochondrial depolarization
GO:2001241 positive regulation of extrinsic apoptotic signaling pathway in absence of ligand
GO:2001269 positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway

Cellular Component:
GO:0000785 chromatin
GO:0005634 nucleus
GO:0005739 mitochondrion
GO:0005758 mitochondrial intermembrane space
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0009898 cytoplasmic side of plasma membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0031966 mitochondrial membrane
GO:0035631 CD40 receptor complex
GO:1905370 serine-type endopeptidase complex


-  Descriptions from all associated GenBank mRNAs
  LF207215 - JP 2014500723-A/14718: Polycomb-Associated Non-Coding RNAs.
AF141305 - Homo sapiens serine protease Htra2 mRNA, alternatively spliced, complete cds.
HV708924 - JP 2012506450-A/22: Methods for treating eye disorders.
HV708925 - JP 2012506450-A/23: Methods for treating eye disorders.
HW061199 - JP 2012529430-A/74: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
HW061200 - JP 2012529430-A/75: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
JA482154 - Sequence 137 from Patent WO2011072091.
JA482155 - Sequence 138 from Patent WO2011072091.
JB252007 - Sequence 74 from Patent EP2440214.
JB252008 - Sequence 75 from Patent EP2440214.
JE980446 - Sequence 137 from Patent EP2862929.
JE980447 - Sequence 138 from Patent EP2862929.
LP764906 - Sequence 74 from Patent EP3276004.
LP764907 - Sequence 75 from Patent EP3276004.
LF213904 - JP 2014500723-A/21407: Polycomb-Associated Non-Coding RNAs.
LF363219 - JP 2014500723-A/170722: Polycomb-Associated Non-Coding RNAs.
AK225932 - Homo sapiens mRNA for Splice isoform 3 of O43464 variant, clone: FCC117B09.
BC000096 - Homo sapiens HtrA serine peptidase 2, mRNA (cDNA clone MGC:1083 IMAGE:3508944), complete cds.
AK291977 - Homo sapiens cDNA FLJ75762 complete cds, highly similar to Homo sapiens protease, serine, 25 (PRSS25), nuclear gene encodingmitochondrial protein, transcript variant 1, mRNA.
AF020760 - Homo sapiens serine protease (OMI) mRNA, complete cds.
AF184911 - Homo sapiens serine protease (OMI) mRNA, alternatively spliced, complete cds.
GQ900899 - Homo sapiens clone HEL-T-11 epididymis secretory sperm binding protein mRNA, complete cds.
AB463757 - Synthetic construct DNA, clone: pF1KB8196, Homo sapiens HTRA2 gene for HtrA serine peptidase 2, without stop codon, in Flexi system.
DQ891822 - Synthetic construct clone IMAGE:100004452; FLH180285.01X; RZPDo839A07134D HtrA serine peptidase 2 (HTRA2) gene, encodes complete protein.
DQ895009 - Synthetic construct Homo sapiens clone IMAGE:100009469; FLH180281.01L; RZPDo839A07133D HtrA serine peptidase 2 (HTRA2) gene, encodes complete protein.
EU176308 - Synthetic construct Homo sapiens clone IMAGE:100006545; FLH263508.01X; RZPDo839A08133D HtrA serine peptidase 2 (HTRA2) gene, encodes complete protein.
KJ898694 - Synthetic construct Homo sapiens clone ccsbBroadEn_08088 HTRA2 gene, encodes complete protein.
AF141306 - Homo sapiens serine protease HtrA2-p7 mRNA, alternatively spliced, partial cds.
AF141307 - Homo sapiens serine protease HtrA2-p4 mRNA, alternatively spliced, partial cds.
AK310163 - Homo sapiens cDNA, FLJ17205.
LF207213 - JP 2014500723-A/14716: Polycomb-Associated Non-Coding RNAs.
JD182584 - Sequence 163608 from Patent EP1572962.
JD096269 - Sequence 77293 from Patent EP1572962.
JD478966 - Sequence 459990 from Patent EP1572962.
JD526869 - Sequence 507893 from Patent EP1572962.
LF363215 - JP 2014500723-A/170718: Polycomb-Associated Non-Coding RNAs.
JD126882 - Sequence 107906 from Patent EP1572962.
JD148709 - Sequence 129733 from Patent EP1572962.
JD250905 - Sequence 231929 from Patent EP1572962.
JD115532 - Sequence 96556 from Patent EP1572962.
JD446767 - Sequence 427791 from Patent EP1572962.
LF363214 - JP 2014500723-A/170717: Polycomb-Associated Non-Coding RNAs.
JD175501 - Sequence 156525 from Patent EP1572962.
MA449481 - JP 2018138019-A/21407: Polycomb-Associated Non-Coding RNAs.
MA598796 - JP 2018138019-A/170722: Polycomb-Associated Non-Coding RNAs.
MA598792 - JP 2018138019-A/170718: Polycomb-Associated Non-Coding RNAs.
MA598791 - JP 2018138019-A/170717: Polycomb-Associated Non-Coding RNAs.
MA442792 - JP 2018138019-A/14718: Polycomb-Associated Non-Coding RNAs.
MA442790 - JP 2018138019-A/14716: Polycomb-Associated Non-Coding RNAs.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000258080.1, ENST00000258080.2, ENST00000258080.3, ENST00000258080.4, ENST00000258080.5, ENST00000258080.6, ENST00000258080.7, HTRA2_HUMAN, NR_135769, O43464, OMI, PRSS25, Q9HBZ4, Q9P0Y3, Q9P0Y4, uc317gax.1, uc317gax.2
UCSC ID: ENST00000258080.8_4
RefSeq Accession: NM_013247.5
Protein: O43464 (aka HTRA2_HUMAN or HRA2_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.